LDX.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: October 20, 2025
Report Source: 2025 Annual Report
Lumos Diagnostics Holdings Ltd. Stock Analysis LDX.AX
Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. The firm offers customized assay development and manufacturing services for POC tests and digital reader platforms. The company also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. The company manages the full development program for POC assays.
Read More Lumos Diagnostics Holdings Ltd (LDX.AX) Chart
Key Statistics of Lumos Diagnostics Holdings Ltd (LDX.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.13Volume
6.58MP/E Ratio (TTM)
-52 Week Range
Market Cap
147.82MAvg. Volume
3.13MDividend Yield
-Financial Metrics & Statements of Lumos Diagnostics Holdings Ltd (LDX.AX)
FAQ's for Lumos Diagnostics Holdings Ltd (LDX.AX)
- According to Musaffa’s Shariah screening methodology, Lumos Diagnostics Holdings Ltd (LDX.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.